CDEK
← All organizations

Newron Pharmaceuticals

For profitContributed to NME

Also known as: Newron | Newron Pharmaceuticals | Newron Pharmaceuticals SPA | Newron Sweden AB

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2004

First marketed drug

Mar 21, 2017

First NDA

Mar 21, 2017

Last known activity

Oct 15, 2025

Timeline

1990s

  1. Jul 1, 1998

    Newron Pharmaceuticals— Founded

2000s

  1. Feb 11, 2008

    Hunter-Fleming Ltd— Acquired

2010s

  1. Jun 13, 2012

    NeuroNova— Acquired

  2. Mar 21, 2017

    safinamide— NDA Organization

Drugs by trial phase (9 distinct, 29 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (33)

Details

Founded
Bresso, Lombardia, IT Jul 1, 1998
First NDA
Mar 21, 2017
Last known activity
Oct 15, 2025